GB1566761A - Benzylpyrrolidines process for their preparation and pharmaceutical compositions containing them - Google Patents

Benzylpyrrolidines process for their preparation and pharmaceutical compositions containing them Download PDF

Info

Publication number
GB1566761A
GB1566761A GB31267/77A GB3126777A GB1566761A GB 1566761 A GB1566761 A GB 1566761A GB 31267/77 A GB31267/77 A GB 31267/77A GB 3126777 A GB3126777 A GB 3126777A GB 1566761 A GB1566761 A GB 1566761A
Authority
GB
United Kingdom
Prior art keywords
group
methylpyrrolidine
addition salts
acid addition
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB31267/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of GB1566761A publication Critical patent/GB1566761A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
GB31267/77A 1976-07-28 1977-07-26 Benzylpyrrolidines process for their preparation and pharmaceutical compositions containing them Expired GB1566761A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75478A LU75478A1 (en, 2012) 1976-07-28 1976-07-28

Publications (1)

Publication Number Publication Date
GB1566761A true GB1566761A (en) 1980-05-08

Family

ID=19728311

Family Applications (1)

Application Number Title Priority Date Filing Date
GB31267/77A Expired GB1566761A (en) 1976-07-28 1977-07-26 Benzylpyrrolidines process for their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (1) US4279918A (en, 2012)
JP (1) JPS5315367A (en, 2012)
AT (1) AT373580B (en, 2012)
AU (1) AU509015B2 (en, 2012)
BE (1) BE857289A (en, 2012)
CA (1) CA1104572A (en, 2012)
CH (1) CH639368A5 (en, 2012)
DE (2) DE2733817A1 (en, 2012)
DK (1) DK339677A (en, 2012)
ES (1) ES461077A1 (en, 2012)
FR (1) FR2359823A1 (en, 2012)
GB (1) GB1566761A (en, 2012)
GR (1) GR61367B (en, 2012)
IE (1) IE45320B1 (en, 2012)
IL (1) IL52611A (en, 2012)
IT (1) IT1085949B (en, 2012)
LU (1) LU75478A1 (en, 2012)
NL (1) NL7708306A (en, 2012)
NZ (1) NZ184755A (en, 2012)
PT (1) PT66858B (en, 2012)
SE (1) SE429338B (en, 2012)
YU (1) YU184277A (en, 2012)
ZA (1) ZA774553B (en, 2012)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
DE2952382A1 (de) * 1979-12-24 1981-07-16 Basf Ag, 6700 Ludwigshafen Phenylpropylammoniumsalze, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
US4826869A (en) * 1988-02-19 1989-05-02 Syntex (U.S.A.) Inc. N-(lower alkyl)-2-(3'ureidobenzyl)pyrrolidines
US5100912A (en) * 1990-05-14 1992-03-31 Syntex (U.S.A.) Inc. Bis(benzylpyrrolidine) derivatives as dopamine agonists
US5135944A (en) * 1989-06-21 1992-08-04 Syntex (U.S.A.) Inc. Bis(benzylpyrrolidine) derivatives useful for treating congestive heart failure and acute renal failure
HUT58050A (en) * 1989-06-21 1992-01-28 Syntex Inc Process for producing 2-(3,4-dialkoxybenzyl)-pyrrolidines
US5093355A (en) * 1989-10-30 1992-03-03 Syntex (U.S.A.) Inc. Benzylpyrrolidine derivatives as dopamine agonists
US5130432A (en) * 1990-12-21 1992-07-14 Syntex (U.S.A.) Inc. Process for preparing cyclic amines and intermediate products thereof
EP0562185A1 (en) * 1992-03-17 1993-09-29 Council of Scientific and Industrial Research 3-(Arylmethyl)-1-(3'-diethylaminopropyl) pyrrolidines and process of preparation thereof
US5248690A (en) * 1992-07-07 1993-09-28 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US7208517B1 (en) * 1994-08-19 2007-04-24 Abbott Labortories Endothelin antagonists
CN104292143A (zh) * 2014-08-17 2015-01-21 湖南华腾制药有限公司 一种2-(4-溴苄基)吡咯烷的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1049380B (de) * 1959-01-29 Bergisch Gladbach Adolf Christian Josef Opfermann Verfahren zur Herstellung von a-substituierten Pyrrolidinen
FR86099E (fr) 1963-08-20 1965-12-03 Pechiney Saint Gobain Dérivés de la delta1-pyrroline
DE1470387A1 (de) 1963-12-20 1969-05-29 Union Carbide Corp Verfahren zur Herstellung von substituierten Pyrrolderivaten
GB1168797A (en) 1965-12-09 1969-10-29 Nat Res Dev Cyclopropane Carboxylic Acid Derivatives and their use as Insecticides
US3647790A (en) * 1969-04-08 1972-03-07 American Home Prod Ouinoxalinyl-oxazolidines and -oxazines

Also Published As

Publication number Publication date
IL52611A0 (en) 1977-10-31
DK339677A (da) 1978-01-29
GR61367B (en) 1978-10-30
FR2359823B1 (en, 2012) 1980-11-21
CA1104572A (en) 1981-07-07
IL52611A (en) 1981-10-30
ZA774553B (en) 1978-06-28
AT373580B (de) 1984-02-10
NZ184755A (en) 1979-12-11
YU184277A (en) 1983-02-28
FR2359823A1 (fr) 1978-02-24
NL7708306A (nl) 1978-01-31
PT66858B (de) 1979-03-13
JPS5315367A (en) 1978-02-13
IT1085949B (it) 1985-05-28
US4279918A (en) 1981-07-21
AU509015B2 (en) 1980-04-17
BE857289A (fr) 1978-01-30
LU75478A1 (en, 2012) 1978-02-08
IE45320B1 (en) 1982-07-28
DE2733817A1 (de) 1978-02-02
SE7708621L (sv) 1978-01-29
IE45320L (en) 1978-01-28
CH639368A5 (de) 1983-11-15
PT66858A (de) 1977-08-01
SE429338B (sv) 1983-08-29
AU2736577A (en) 1979-02-01
ATA548177A (de) 1983-06-15
ES461077A1 (es) 1978-12-01
DE2733753A1 (de) 1978-02-02

Similar Documents

Publication Publication Date Title
US4229453A (en) Substituted 5,6-dimethylpyrrolo[2,3-d]pyrimidine compounds, their production and their medicinal use
DE3717561A1 (de) Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB1566761A (en) Benzylpyrrolidines process for their preparation and pharmaceutical compositions containing them
US4564613A (en) Pyridoindole derivatives, compositions and use
EP0414422B1 (en) 2-Oxo-1-oxa-8-azaspiro [4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof
NO139685B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater
US4021552A (en) 10-[ω-(BENZOYLPIPERIDINYL)ALKYL]PHENOTHIAZINES
US4975431A (en) Certain anti-inflammatory cyclohepta[b]pyridines and analogs thereof
US4045448A (en) Pyrrolo[2,1-c][1,4]benzoxazepine and benzoxazocine derivatives
EP0368188B1 (en) 1,2,3,4-Tetrahydro-1,9-acridinediamines, a process for their preparation and their use as medicaments
EP0116347B1 (en) Substituted 1-azaspiro(4.5)decanes and 1-azaspiro(5.5)-undecanes, intermediates and a process for their preparation, and their use as medicaments
US4198424A (en) Substituted 1-phenyl-2-pyrrolidin-2-yl-ethanols, their synthesis, their use and their compositions
US4254135A (en) 3-Amino-4-hydroxypyrrolidines
EP0233049A1 (en) 2,3,4,8,9,9a-Hexahydro-4-aryl-1H-indeno[1,7-cd]azepines
EP0194112A1 (en) 3-Aryl-oxyazetidinecarboxamides having anti-muscle tension, anti-muscle spasticity, anticonvulsant and antiepilectic activity
US3972994A (en) Disubstituted azabicycloalkanes
EP0670313A1 (en) Spiro compounds, their production and use
US4221788A (en) 2-(Optionally-substituted)benzylperhydroazepines for analgesia and lowering blood pressure
US3729465A (en) Hexahydroazepines
AU702454B2 (en) Anxiolytic agent
CA1080705A (en) Azabicycloalkanes and precursors thereof
CA1140930A (en) Heterocyclic spiro-linked amidines, their stereoisomers and optical isomers, processes for their preparation and medicaments containing these compounds
GB1593223A (en) 2-benzylperhydroazepines process for their preparation and pharmaceutical compositions containing them
EP0401779B1 (en) 4,5,5a,6-Tetrahydro-3H-isoxazolo (5,4,3-kl)acridines derivatives, a process for their preparation and their use as medicaments
AT376659B (de) Verfahren zur herstellung von neuen substituierten 2-benzylpyrrolidinen

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee